Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

George T. O’Connor, William W. Busse, Stephen R. Durham, Leonard B. Bacharier, Carole Ober, James E. Gern, DAVID L. LARSON, Stephane J. Esnault, Alkis G. Togias, Robert A. Wood, Peter J. Gergen, Daniel J. Jackson, Meyer Kattan, Cynthia M. Visness, Patrice M. Becker, Mathew C. Altman
2020-04-22

ACE2 expressionallergic asthmanasal and bronchial epithelial RNA-seqrespiratory allergytype 2 inflammation (IL-13)
The novel coronavirus SARS-CoV-2 (COVID-19) was recognized in December 2019 as a cause of severe pneumonia and has now led to a global pandemic.1 Respiratory illnesses caused by COVID-19 cover a range of severity. The identification of risk and protective factors for disease severity from COVID-19 is critical to direct development of new treatments and infection prevention strategies. Early large case series have identified a number of risk factors for severe disease, including older age, hypertension, diabetes, cardiovascular disease, tobacco exposure, and chronic obstructive pulmonary disease.
1
ACE2 expression inversely correlates with type 2 biomarkers: number of positive allergen-specific IgE (β=-0.089; P=3.1E–5), total IgE (β=-0.31; P=5.1E–6), fractional exhaled nitric oxide (β=-0.45; P=3.4E–3), and nasal IL13 expression (β=-0.123; P=8.6E–5).
2
Allergen challenge studies show acute reductions in ACE2: nasal cat allergen challenge (FC=0.81; P=2.4E–3), environmental exposure chamber (FC=0.79; P=1.6E–3), and segmental bronchoprovocation reduced lower airway ACE2 (FC=0.64; P=0.01).
3
Children with asthma and moderate (FC=0.70; P=4.2E–3) or high (FC=0.54; P=6.4E–5) allergic sensitization show progressively greater reductions in nasal ACE2 expression versus minimal-sensitized asthmatic children.
4
In vitro IL-13 exposure reduces ACE2 expression in differentiated airway epithelial cells (nasal FC=0.44; P=5.8E–4; bronchial FC=0.80; P=5.1E–3), suggesting type 2 inflammation mediates ACE2 downregulation.
5
Respiratory allergy and controlled allergen exposures are each associated with significant reductions in ACE2 gene expression in airway epithelial cells.

Airway (nasal and bronchial) epithelial cells from children and adults with respiratory allergy and asthma

Expression level of the SARS-CoV-2 receptor ACE2 and its association with respiratory allergy, allergic sensitization, type 2 biomarkers, and allergen exposure

Publication Details
Publication Date
2020-04-22
Journal
Publisher
ISSN
Cited by
568
Access Type
Author Information
Authors
George T. O’Connor
William W. Busse
Stephen R. Durham
Leonard B. Bacharier
Carole Ober
James E. Gern
DAVID L. LARSON
Stephane J. Esnault
Alkis G. Togias
Robert A. Wood
Peter J. Gergen
Daniel J. Jackson
Meyer Kattan
Cynthia M. Visness
Patrice M. Becker
Mathew C. Altman
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%